Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

…, CJ Fang, MK Liszewski, D Kavanagh, JP Atkinson… - Blood, 2006 - ashpublications.org
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy with manifestations of
hemolytic anemia, thrombocytopenia, and renal impairment. Genetic studies have shown that …

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

T Seya, JR Turner, JP Atkinson - The Journal of experimental medicine, 1986 - rupress.org
Based on preliminary evidence indicating that a cell-associated protein of U937 (a human
monocyte-like cell line) possessed cofactor activity and was not the C3b/C4b receptor, we …

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

…, JM Green, KA Brett, KM Murphy, JP Atkinson - Nature, 2003 - nature.com
The immune system must distinguish not only between self and non-self, but also between
innocuous and pathological foreign antigens to prevent unnecessary or self-destructive …

Immunology of age-related macular degeneration

J Ambati, JP Atkinson, BD Gelfand - Nature Reviews Immunology, 2013 - nature.com
Age-related macular degeneration (AMD) is a leading cause of blindness in aged
individuals. Recent advances have highlighted the essential role of immune processes in the …

Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration

…, E Souied, N Katsanis, MJ Daly, JP Atkinson… - Nature …, 2013 - nature.com
To define the role of rare variants in advanced age-related macular degeneration (AMD) risk,
we sequenced the exons of 681 genes within all reported AMD loci and related pathways …

[PDF][PDF] Human T regulatory cells can use the perforin pathway to cause autologous target cell death

…, JW Verbsky, W Barchet, M Colonna, JP Atkinson… - Immunity, 2004 - cell.com
Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill
virally infected cells and tumor cells. Mutations in genes important for this pathway are …

Hereditary angioedema: the clinical syndrome and its management

…, JA GELFAND, JP ATKINSON - Annals of Internal …, 1976 - acpjournals.org
Hereditary angioedema is manifested by attacks of swelling of the extremities, face, trunk,
airway, or abdominal viscera, occurring spontaneously or secondary to trauma. It is inherited …

Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells

…, JW Verbsky, BL Tollefsen, C Kemper, JP Atkinson… - Blood, 2004 - ashpublications.org
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells use the perforin/granzyme pathway
as a major mechanism to kill pathogen-containing cells and tumor cells. Dysregulation of …

Decay-accelerating factor: biochemistry, molecular biology, and function

DM Lublin, JP Atkinson - Annual review of immunology, 1989 - annualreviews.org
Complement components regularly become anchored to host cells as well as to microbes.
These components must be allowed to promote the reaction cascade on microbes but must …

Control of the complement system.

…, DM Lublin, IA Rooney, JP Atkinson - Advances in …, 1996 - europepmc.org
The complement system has developed a remarkably simple but elegant manner of regulating
itself. It has faced and successfully dealt with how to facilitate activation on a microbe …